{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:59:25Z","timestamp":1792025965355,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":528,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K12 CA184746"],"award-info":[{"award-number":["K12 CA184746"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41379-021-00799-6","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T03:02:51Z","timestamp":1616727771000},"page":"1570-1587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-7333","authenticated-orcid":false,"given":"Edaise M.","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Fix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Martins","family":"Sebastiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier","family":"Selenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4025-7930","authenticated-orcid":false,"given":"Lorenzo","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthe","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Da Cruz Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3748-8049","authenticated-orcid":false,"given":"Fresia","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5406-4104","authenticated-orcid":false,"given":"Ahmet","family":"Zehir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Konner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cadoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-3173","authenticated-orcid":false,"given":"Jorge S.","family":"Reis-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-1270","authenticated-orcid":false,"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8989-2938","authenticated-orcid":false,"given":"Kay J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00799-6_bib1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00000478-199012000-00002","article-title":"Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases","volume":"14","author":"Ferry","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib3","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224758","article-title":"Mesonephric adenocarcinoma of the vagina masquerading as a suburethral cyst","volume":"2018","author":"Shoeir","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1038\/s41379-021-00799-6_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00066-016-1004-x","article-title":"Mesonephric adenocarcinoma of the vagina: Diagnosis and multimodal treatment of a rare tumor and analysis of worldwide experience","volume":"192","author":"Mueller","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1038\/s41379-021-00799-6_bib6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/PGP.0000000000000088","article-title":"Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity for PAX2, PAX8, and GATA-3","volume":"33","author":"Roma","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib7","first-page":"157","article-title":"Non-diethylstilbestrol exposed vaginal adenocarcinoma in young patients associated with unilateral renal agenesis: two case reports and literature review","volume":"38","author":"Plesinac-Karapandzic","year":"2017","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1038\/s41379-021-00799-6_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00799-6_bib9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib12","first-page":"7012","article-title":"Mesonephric adenocarcinoma of the uterine corpus","volume":"7","author":"Wu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200405000-00006","article-title":"Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases","volume":"28","author":"Bague","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1746-1596-8-74","article-title":"Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature","volume":"8","author":"Meguro","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PGP.0000000000000573","article-title":"Ovarian combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a mullerian origin of mesonephric-like adenocarcinoma","volume":"39","author":"McCluggage","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a mullerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-020-01012-z","article-title":"Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis","volume":"15","author":"Dundr","year":"2020","journal-title":"Diagn Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-019-0830-4","article-title":"Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Mullerian duct lineage: a case report","volume":"14","author":"Yano","year":"2019","journal-title":"Diagn Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pathol.2017.11.084","article-title":"Mesonephric proliferations of the female genital tract","volume":"50","author":"Howitt","year":"2018","journal-title":"Pathology"},{"key":"10.1038\/s41379-021-00799-6_bib20","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib21","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAS.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior","volume":"44","author":"Euscher","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium","volume":"43","author":"Kolin","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1038\/s41379-021-00799-6_bib25","unstructured":"Kurman RJCM, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. Vol. 6, 4th ed. Lyon, France: IARC; 2014."},{"key":"10.1038\/s41379-021-00799-6_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1038\/s41379-021-00799-6_bib27","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41379-020-0514-3","article-title":"Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary","volume":"33","author":"Da Cruz Paula","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djy028","article-title":"The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers","volume":"110","author":"Weigelt","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-021-00799-6_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04128-5","article-title":"Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas","volume":"9","author":"Geyer","year":"2018","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-021-00799-6_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1038\/s41379-021-00799-6_bib31","article-title":"Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-021-00799-6_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1038\/s41379-021-00799-6_bib33","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-021-00799-6_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"10.1038\/s41379-021-00799-6_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s42003-018-0023-9","article-title":"Genome-wide somatic variant calling using localized colored de Bruijn graphs","volume":"1","author":"Narzisi","year":"2018","journal-title":"Commun Biol"},{"key":"10.1038\/s41379-021-00799-6_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nmeth.3069","article-title":"Accurate de novo and transmitted indel detection in exome-capture data using microassembly","volume":"11","author":"Narzisi","year":"2014","journal-title":"Nat Methods"},{"key":"10.1038\/s41379-021-00799-6_bib37","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-021-00799-6_bib38","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/s41379-021-00799-6_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1038\/s41379-021-00799-6_bib40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/jnci\/djy216","article-title":"The genomic landscape of mucinous breast cancer","volume":"111","author":"Pareja","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-021-00799-6_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/2159-8290.CD-17-0321","article-title":"Accelerating discovery of functional mutant alleles in cancer","volume":"8","author":"Chang","year":"2018","journal-title":"Cancer Disco"},{"key":"10.1038\/s41379-021-00799-6_bib42","article-title":"Radiogenomics analysis of intratumor heterogeneity in a patient with high-grade serous ovarian cancer","volume":"3","author":"Weigelt","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1038\/s41379-021-00799-6_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","article-title":"Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma","volume":"146","author":"Horn","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1038\/s41379-021-00799-6_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1038\/s41379-021-00799-6_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-19-1167","article-title":"The KRAS(G12C) inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients","volume":"10","author":"Hallin","year":"2020","journal-title":"Cancer Disco"},{"key":"10.1038\/s41379-021-00799-6_bib46","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS(G12C) inhibition with sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-021-00799-6_bib47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jamaoncol.2016.5281","article-title":"Targeting the PI3K\/AKT\/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer: evidence from a phase 1 trial of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab","volume":"3","author":"Basho","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1038\/s41379-021-00799-6_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13000-019-0847-8","article-title":"Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis","volume":"14","author":"Montalvo","year":"2019","journal-title":"Diagn Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/PGP.0000000000000102","article-title":"Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix","volume":"33","author":"Goyal","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3109\/01443615.2016.1157155","article-title":"A case of mesonephric adenocarcinoma of the uterine cervix mimicking an endometrial clear cell carcinoma in the curettage specimen","volume":"36","author":"Kir","year":"2016","journal-title":"J Obstet Gynaecol"},{"key":"10.1038\/s41379-021-00799-6_bib51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0000000000000306","article-title":"Mixed mesonephric adenocarcinoma and high-grade neuroendocrine carcinoma of the uterine cervix: case description of a previously unreported entity with insights into its molecular pathogenesis","volume":"36","author":"Cavalcanti","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0000000000000986","article-title":"International endocervical adenocarcinoma criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix","volume":"42","author":"Stolnicu","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00799-6_bib53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00799-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:36:14Z","timestamp":1760229374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0893395222005713"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00799-6","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00799-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}